FUJIFILM Corporation emite los comunicados de prensa en Japón.
Fujifilm no declara que los productos de estos comunicados de prensa estén disponibles comercialmente en todos los países y regiones.
Tenga en cuenta que el contenido de este sitio web está actualizado a la fecha del anuncio de prensa y puede estar sujeto a cambios sin previo aviso. La información de cada versión, incluida la disponibilidad de los productos, las especificaciones, los precios y los contactos, se corresponde con la del momento de la publicación.
- Dic 12, 2022
- Fujifilm to Build an Advanced Semiconductor Materials Manufacturing Facility in South Korea
- Nov 22, 2022
- Fujifilm Invests $188 Million in New Cell Culture Media Manufacturing Facility
- Oct 18, 2022
- Fujifilm develops “FUJINON HZK25-1000mm”
- Oct 5, 2022
- Fujifilm to establish its first Bio-CDMO site in Japan
- Oct 2, 2022
- Fujifilm to establish a local subsidiary in South Korea to accelerate business growth of cell culture media
- Sep 7, 2022
- Fujifilm announces a strategic investment in a new production facility in Kumamoto Japan to support the fast-growing semiconductor industry
- Jul 5, 2022
- Fujifilm launches FUJIFILM PROJECTOR Z6000
- Jun 29, 2022
- Fujifilm to Invest USD 1.6 billion to enhance and expand its global offering of cell culture manufacturing services
- Jun 7, 2022
- Fujifilm Acquires European Inkjet System Integrator UNIGRAPHICA to Expand Inkjet Integration Business Globally
- May 8, 2022
- Fujifilm reveals FUJIFILM PROJECTOR Z6000
- Abr 4, 2022
- Fujifilm Completes Acquisition of a Dedicated Cell Therapy Manufacturing Facility from Atara Biotherapeutics, Inc.
- Mar 28, 2022
- Fujifilm Completes Acquisition of Shenandoah Biotechnology
- Mar 27, 2022
- Fujifilm Invests in a new manufacturing facility for inkjet pigment dispersions in the U.S.
- Mar 22, 2022
- Fujifilm to Acquire Shenandoah Biotechnology, Leading Manufacturer of Recombinant Proteins
- Ene 26, 2022
- Fujifilm Expands its Advanced Therapies CDMO Business with the Acquisition of a Dedicated Cell Therapy Manufacturing Facility from Atara Biotherapeutics, Inc.
- Dic 8, 2021
- Fujifilm Kicks Off Operations at its New, State-of-the-Art Cell Culture Media Manufacturing Facility in Europe
- Nov 30, 2021
- FUJIFILM Irvine Scientific Establishes a Bioprocessing Innovation and Collaboration Center in China (FUJIFILM Irvine Scientific)
- Oct 19, 2021
- Fujifilm launches 4K-compatible broadcast lens with 107× zoom “FUJINON UA107x8.4BESM”
- Sep 30, 2021
- Fujifilm agrees on core terms with Australian regenerative medicine venture Cynata to manufacture Cynata’s iPS cell-derived regenerative medicine products
- Sep 6, 2021
-
Fujifilm Launches LTO Ultrium9 Data Cartridge
-Magnetic tape storage media with maximum storage capacity of 45TB
-Providing safe long-term storage of high-volume data at low cost
-Significantly mitigating CO2 emissions